G Chenevix-Trench

The use of the Illumina FFPE Restoration Protocol to obtain suitable quality DNA for SNP-based CGH– a pilot study

G. Chenevix-Trench, S. Cocciardi, AN Hosein, 2012, Hereditary Cancer in Clinical Practice.

Expression of beta-catenin, a key mediator of the WNT signaling pathway, in basal cell carcinoma.

G Chenevix-Trench, W Boonchai, M Walsh, 2000, Archives of dermatology.

Analysis of the TGFβ functional pathway in epithelial ovarian carcinoma

A. Shelling, G. Chenevix-Trench, I. Winship, 2001, British Journal of Cancer.

Medulloblastomas of the desmoplastic variant carry mutations of the human homologue of Drosophila patched.

T Pietsch, F. Berthold, G. Chenevix-Trench, 1997, Cancer research.

The Australian Ovarian Cancer Study

N. Traficante, S. Fereday, J. Hung, 2012, Hereditary Cancer in Clinical Practice.

Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA)

G Rennert, N Weerasooriya, K Offit, 2009, British Journal of Cancer.